These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23294261)

  • 41. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
    Markvardsen LH; Christiansen I; Harbo T; Jakobsen J
    Eur J Neurol; 2014; 21(1):147-52. PubMed ID: 24180709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Severe hemolytic anemia caused by anti-AB in renal transplantation with minor ABO incompatibility].
    Ríos Rull P; Rodríguez Pérez A; Ibáñez García A; Arrieta R; De la Cámara C
    Sangre (Barc); 1992 Jun; 37(3):197-9. PubMed ID: 1440097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
    Welsh KJ; Bai Y
    J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
    Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
    Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.
    Hemmila MR; Foley DS; Castle VP; Hirschl RB
    J Pediatr Surg; 2000 Jun; 35(6):967-71; discussion 971-2. PubMed ID: 10873046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of IgG and IgM anti-A with synthetic oligosaccharides.
    Romano EL; Bhardwaj J; Kelly S; Olson M; Lamontagne LR; Leigh JB; Lauzon GJ
    Transplant Proc; 1987 Dec; 19(6):4479-83. PubMed ID: 3321604
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe immune haemolysis in a group A recipient of a group O red blood cell unit.
    Barjas-Castro ML; Locatelli MF; Carvalho MA; Gilli SO; Castro V
    Transfus Med; 2003 Aug; 13(4):239-41. PubMed ID: 12880395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralization of ABO blood group antibodies by specific oligosaccharides.
    Romano EL; Soyano A; Linares J; Lauzon GJ
    Transplant Proc; 1987 Dec; 19(6):4426-30. PubMed ID: 3424436
    [No Abstract]   [Full Text] [Related]  

  • 51. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura.
    Gwilliam NR; Lazar DA; Brandt ML; Mahoney DH; Wesson DE; Mazziotti MV; Nuchtern JG; Lee TC
    J Pediatr Surg; 2012 Aug; 47(8):1537-41. PubMed ID: 22901913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of idiopathic thrombocytopenic purpura in elderly patients.
    Andrès E; Daou S; Zimmer J; Federici L; Maloisel F
    Eur J Haematol; 2007 Feb; 78(2):175. PubMed ID: 17313565
    [No Abstract]   [Full Text] [Related]  

  • 53. Immune hemolysis-serological and clinical aspects.
    Pruss A; Salama A; Ahrens N; Hansen A; Kiesewetter H; Koscielny J; Dörner T
    Clin Exp Med; 2003 Sep; 3(2):55-64. PubMed ID: 14598182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemolysis in ABO-incompatible liver transplantation.
    Angstadt J; Jarrell B; Maddrey W; Munoz S; Yang SL; Moritz M; Carabasi A
    Transplant Proc; 1987 Dec; 19(6):4595-7. PubMed ID: 3321627
    [No Abstract]   [Full Text] [Related]  

  • 55. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal failure and intravenous immunoglobulin.
    Phillips AO
    Clin Nephrol; 1992 Apr; 37(4):217. PubMed ID: 1582064
    [No Abstract]   [Full Text] [Related]  

  • 57. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.
    Mitterer M; Pescosta N; Vogetseder W; Mair M; Coser P
    Ann Hematol; 1993 Sep; 67(3):151-2. PubMed ID: 8373906
    [No Abstract]   [Full Text] [Related]  

  • 58. Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.
    Rubinstein PG; Chen YH
    Am J Hematol; 2008 Aug; 83(8):684-5. PubMed ID: 18508323
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe chronic idiopathic thrombocytopenic purpura during childhood: definition, management, and prognosis.
    Buchanan GR; Journeycake JM; Adix L
    Semin Thromb Hemost; 2003 Dec; 29(6):595-603. PubMed ID: 14719176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The treatment of patients with autoimmune thrombocytopenia with intravenous IgG-anti-D.
    Engelfriet CP; Reesink HW; Bussel J; Godeau B; Bierling P; Panzer S; Grümayer-Panzer ER; Mayr WR; Neppert J; Taaning E; Minchinton R; Bowman JM
    Vox Sang; 1999; 76(4):250-5. PubMed ID: 10454936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.